Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.
Press releases published on May 7, 2025

Krishnan Suthanthiran, President/Founder TeamBest Global, to Host Major Press Conference in New Delhi on May 17, 2025
Announcing New Initiatives in Health, Innovation, and Global Indian Engagement WASHINGTON, DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Dr. Krishnan Suthanthiran, President and Founder of TeamBest Global Companies and the Best Cure Foundation, …

Soccer Legend Luis 'El Matador' Hernandez Joins the NHMA to Amplify Diverse Voices at 28th Annual Conference in Anaheim
The largest Latino medical association convenes to advance health equity in our communities WASHINGTON, DC, DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- The National Hispanic Medical Association (NHMA) welcomes Mexican soccer legend and vaccine …

Live From Gaza: Doctors Fighting to Spare Thousands of Children From Starvation to Issue Plea in International ZOOM Call
Providers struggling against catastrophic conditions in northern Gaza while witnessing a child dying every 40 minutes are begging: Let the children eat! WASHINGTON (DC), DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- In Gaza, the World Food …

COLORECTAL CANCER ALLIANCE LAUNCHES 'SCREEN SMART' TO MAKE LIFESAVING CANCER SCREENINGS EASIER FOR EVERYONE
Survey Shows Americans Avoid CRC Screenings Due to Conflicts and Confusion WASHINGTON, DC, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- Laundry, childcare—even filing taxes—are being prioritized over potentially lifesaving colorectal cancer (CRC) …

Navigating Alzheimer’s: Empowering Caregivers with Compassionate, Non-Medication Approaches to Neuropsychiatric Symptoms
Practical strategies for families of loved ones with Alzheimer's who are navigating the challenges of neuropsychiatric symptoms (NPS) like agitation …

CHESS Health Solutions Launches Medicaid Clinically Integrated Network to Support North Carolina Providers and Patients
Winston-Salem, NC, May 07, 2025 (GLOBE NEWSWIRE) -- CHESS Health Solutions is proud to announce the launch of its Medicaid Clinically Integrated Network (CIN), a strategic model designed to help providers navigate the complexities of North Carolina’s …

Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to $12.4 …

Viemed Healthcare Announces First Quarter 2025 Financial Results
LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its …

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …

Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 Mont-Saint-Guibert, Belgium – Wednesday May 7, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough …

Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025
Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2025 le 14 Mai 2025 Mont-Saint-Guibert, Belgique – 7 mai 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie …

STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders …

Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced today that JCO Precision Oncology published a real-world study suggesting that the results of …

DLH Reports Fiscal 2025 Second Quarter Results
ATLANTA, May 07, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates
— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD) on track for the second half of 2025 — Streamlining operations and focusing on delivering potential value generating program milestones, with …

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
Catalyst Enters 2025 With Strong Momentum; Reiterates Confidence in Full-Year Outlook Delivers Record Q1 2025 Total Revenues of $141.4 Million, a 43.6% YoY Increase FIRDAPSE® and AGAMREE® Drive Sustained Organic Growth, Underscoring Execution Strength …

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
MELBOURNE, Australia and INDIANAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been …

Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update
- Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial ongoing with clinical data update at 2025 ASCO® Annual Meeting - Based on the Company’s current operating plan, existing cash, cash equivalents and marketable securities …

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 7, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …

GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager le …